What is Biological Industries?
Founded in 1981 and headquartered near Haifa, Israel, Biological Industries is a key player in the development and manufacturing of cell culture media. The company's primary focus lies in providing essential components for cell and gene therapy, regenerative medicine, and other cutting-edge therapeutic applications. With a dedicated workforce of approximately 130 employees, Biological Industries operates from its main R&D and production facility, complemented by sales offices in the USA, Europe, and China, ensuring a global reach for its specialized products.
How much funding has Biological Industries raised?
Biological Industries has raised a total of $50M across 1 funding round:
Share Placement
$50M
Share Placement (2019): $50M with participation from Sartorius
Key Investors in Biological Industries
Sartorius
Sartorius is a leading international partner of life science research and the biopharmaceutical industry. Their investment likely signifies a strategic alignment with Biological Industries' advancements in cell and gene therapy media.
What's next for Biological Industries?
The substantial enterprise-level funding, including the recent strategic investment, positions Biological Industries for accelerated expansion and innovation. This capital infusion is expected to fuel further research and development into novel cell culture solutions, enhance manufacturing capabilities, and broaden its market penetration. The company's established presence in critical life science sectors suggests a strategic focus on scaling operations to meet the growing global demand for advanced therapeutic development tools.
See full Biological Industries company page
